Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02146833
Title Study of Selinexor (KPT-330) in Metastatic Castrate Resistant Prostate Adenocarcinoma
Acronym SHIP
Recruitment Terminated
Gender male
Phase Phase II
Variant Requirements No
Sponsors Karyopharm Therapeutics, Inc
Age Groups: adult
Covered Countries USA

No variant requirements are available.